Pyxis Oncology
Antibody-drug conjugate (ADC) and immune-oncology platform for solid tumor treatment
- Sector
- Biotech
- Founded
- 2018
- Latest Form D
- $172M, Mar 2021
- Total capital
- $194M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $194M
- 2 Form D · last Mar 2021
- 67 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 17 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$172M
- Private capital raisedForm D · SEC · 1st filing$22M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Christian SchetterDirectorNamed in SEC Form D filings
- Christopher O?DonnellDirectorNamed in SEC Form D filings
- Christoph WestphalDirectorNamed in SEC Form D filings
- David SteinbergDirectorNamed in SEC Form D filings
- Geeta VemuriDirectorNamed in SEC Form D filings
- Gotham MakkerDirectorNamed in SEC Form D filings
Show all 11 people
- Jak KnowlesDirectorNamed in SEC Form D filings
- John FlavinDirectorNamed in SEC Form D filings
- Lara SullivanExecutive Officer, DirectorNamed in SEC Form D filings
- Lucio IannoneDirectorNamed in SEC Form D filings
- Robert CraneExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 17- PendingLigand-payload ConjugatesUSPTOApplication 18850092
- PendingConstructs, Compositions, And Methods For Treating Extra Domain B Splice Variant Of Fibronectin-expressing Diseases And DisordersUSPTOApplication PCTUS2025022160
- PendingConstructs, Compositions, And Methods For Treating Edb+ Fn-expressing Diseases And DisordersUSPTOApplication 63722504
Show all 17 patent records
- Ligand-payload ConjugatesDec 25, 2025 · Application 18850092Pending
- Constructs, Compositions, And Methods For Treating Extra Domain B Splice Variant Of Fibronectin-expressing Diseases And DisordersApplication PCTUS2025022160Pending
- Constructs, Compositions, And Methods For Treating Edb+ Fn-expressing Diseases And DisordersApplication 63722504Pending
- Constructs, Compositions, And Methods For Treating EDB+ FN-Expressing Diseases And DisordersApplication 63714650Pending
- ANTI-KLRG1 Antibodies And Uses ThereofApplication PCTUS2024034971Pending
- Constructs, Compositions, And Methods For Treating EDB+ FN-Expressing Diseases And DisordersApplication 63571754Pending
- ANTI-KLRG1 Antibodies And Uses ThereofApplication 63509850Pending
- Ligand-payload ConjugatesApplication PCTUS2023065173Pending
- Gpnmb Antibodies And Methods Of UseApplication PCTUS2022023041Pending
- Ligand-payload Conjugates With Branched LinkersApplication 63362149Pending
- Site-specific Ligand-payload ConjugatesApplication 63362145Pending
- In Silico Generated Target ListsApplication PCTUS2021037004Pending
- Gpnmb Antibodies And Methods Of UseApplication 63169574Pending
- In Silico Generated Target ListsApplication 63040600Pending
- In Silico Generated Target ListsApplication 63037687Pending
- Constructs, Compositions, And Methods For Treating Diseases And Disorders Expressing Extra Domain B Splice Variant Of FibronectinApplication PCTUS2025056099Pending
- ANTI-KLRG1 Antibodies And Uses ThereofApplication 19495123Pending
Related companies, and why
- Trove Labs IncSimilar federal contract value in Biotech · null in contracts
- Third Arc Bio, Inc.Similar federal contract value in Biotech · null in contracts
- 4D Molecular Therapeutics IncSimilar federal contract value in Biotech · null in contracts
- Imago BioSciencesSimilar federal contract value in Biotech · null in contracts
- Dianthus Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Applied Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .